ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $12,000 | +200.0% | 500 | +66.7% | 0.00% | +100.0% |
| Q4 2018 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |